Myeloid cells in tumor inflammation

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• Bone marrow-derived myeloid cells infiltrate tumors, creating a pro-tumorigenic inflammatory microenvironment.
• Key myeloid cell populations include monocytic and granulocytic myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs).
• These myeloid cells are linked to poor clinical outcomes in cancer patients.

Purpose of the Study:

• To elucidate the role of tumor-infiltrating myeloid cells in promoting cancer progression.
• To highlight the mechanisms by which MDSCs and TAMs contribute to tumor growth, spread, and therapy resistance.
• To underscore the therapeutic potential of targeting these myeloid cell populations.

Main Methods:

• Analysis of myeloid cell accumulation within tumor microenvironments.
• Characterization of MDSC and TAM populations and their functions.
• Review of existing literature on myeloid cell involvement in cancer.

Main Results:

• Myeloid cells, primarily MDSCs and TAMs, are consistently found in tumors.
• These cells actively promote immunosuppression, neovascularization, and metastasis.
• MDSCs and TAMs contribute to resistance against anti-cancer therapies.

Conclusions:

• Targeting the tumor-promoting functions of myeloid cells is a viable therapeutic strategy.
• Interventions aimed at myeloid cells could significantly improve treatment outcomes for cancer patients.
• Further research into targeting myeloid cell functions is warranted.